A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 27 400 KRW 3.79% Market Closed
Market Cap: 1.3T KRW
Have any thoughts about
ABL Bio Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
ABL Bio Inc

Current Assets 36.1B
Cash & Short-Term Investments 33.7B
Receivables 434.8m
Other Current Assets 2B
Non-Current Assets 84.6B
Long-Term Investments 1.7B
PP&E 79.9B
Intangibles 2.5B
Other Non-Current Assets 523.3m
Current Liabilities 23.4B
Accrued Liabilities 309.3m
Other Current Liabilities 23.1B
Non-Current Liabilities 44.2B
Long-Term Debt 43B
Other Non-Current Liabilities 1.2B

Balance Sheet
ABL Bio Inc

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
5 340
1 996
122 035
91 146
40 658
21 589
25 136
28 064
Cash Equivalents
5 340
1 996
122 035
91 146
40 658
21 589
25 136
28 064
Short-Term Investments
0
7 174
32 865
42 141
29 733
22 058
53 174
43 085
Total Receivables
77
10
5 745
755
1 394
208
573
2 003
Accounts Receivables
0
0
5 386
9
865
3
4
51
Other Receivables
0
0
359
746
2 259
205
569
1 952
Other Current Assets
279
257
446
614
135
1 618
1 652
2 386
Total Current Assets
5 695
9 437
161 091
134 657
71 920
45 472
80 535
75 539
PP&E Net
1 483
1 924
2 699
5 042
4 065
3 304
6 713
76 035
PP&E Gross
1 483
1 924
2 699
5 042
4 065
3 304
6 713
76 035
Accumulated Depreciation
155
521
1 072
2 513
4 426
6 251
6 230
8 169
Intangible Assets
270
369
507
2 753
2 708
2 556
2 610
2 534
Long-Term Investments
0
8 512
4 371
0
20 620
13 503
93 634
2 743
Other Long-Term Assets
83
128
200
450
582
617
1 689
3 294
Total Assets
7 530
N/A
20 370
+171%
168 869
+729%
142 903
-15%
99 894
-30%
65 453
-34%
185 181
+183%
160 144
-14%
Liabilities
Accrued Liabilities
11
7
13
30
98
16
184
165
Short-Term Debt
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
801
940
502
1 167
784
Other Current Liabilities
292
1 337
11 573
8 496
6 930
8 232
70 821
40 810
Total Current Liabilities
303
1 344
11 586
9 327
7 969
8 750
72 172
41 760
Long-Term Debt
2 327
7 628
0
1 079
555
72
40 669
43 154
Other Liabilities
16 999
97 353
321
488
706
677
2 826
1 152
Total Liabilities
19 629
N/A
106 325
+442%
11 907
-89%
10 895
-8%
9 230
-15%
9 500
+3%
115 667
+1 118%
86 065
-26%
Equity
Common Stock
96
96
22 294
22 652
23 123
23 562
23 894
23 946
Retained Earnings
13 685
88 489
205 693
243 285
299 059
342 535
339 134
342 345
Additional Paid In Capital
1 489
2 437
332 918
334 393
342 465
348 732
361 173
363 760
Other Equity
0
0
7 443
18 248
24 136
26 194
23 580
28 718
Total Equity
12 099
N/A
85 955
-610%
156 962
N/A
132 008
-16%
90 665
-31%
55 953
-38%
69 513
+24%
74 079
+7%
Total Liabilities & Equity
7 530
N/A
20 370
+171%
168 869
+729%
142 903
-15%
99 894
-30%
65 453
-34%
185 181
+183%
160 144
-14%
Shares Outstanding
Common Shares Outstanding
19
19
45
45
46
47
48
48

See Also

Discover More